SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027424
Filing Date
2018-11-06
Accepted
2018-11-06 16:16:34
Documents
61
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pti-10q_20180930.htm 10-Q 2072747
2 EX-31.1 pti-ex311_13.htm EX-31.1 12062
3 EX-31.2 pti-ex312_10.htm EX-31.2 12010
4 EX-32.1 pti-ex321_7.htm EX-32.1 13246
  Complete submission text file 0001564590-18-027424.txt   6744827

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pti-20180930.xml EX-101.INS 1551691
6 XBRL TAXONOMY EXTENSION SCHEMA pti-20180930.xsd EX-101.SCH 39901
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pti-20180930_cal.xml EX-101.CAL 46083
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pti-20180930_def.xml EX-101.DEF 130587
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pti-20180930_lab.xml EX-101.LAB 302034
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pti-20180930_pre.xml EX-101.PRE 232120
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-37695 | Film No.: 181163187
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1